Clinical Trial Update: JAVLOR Association Study in CDDP-unfit Patients With Advanced Transitional Cell Carcinoma: Gemcitabine Versus Carboplatin [Phase 2]

View source ↗

Summary

Phase 2 trial comparing gemcitabine versus carboplatin in cisplatin-unfit patients with advanced transitional cell carcinoma of the bladder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Transitional Cell Carcinoma of the Bladder

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: Pierre Fabre Medicament | Conditions: Bladder Transitional Cell Carcinoma Stage IV | Phase 2 | Status: COMPLETED